Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
ESS Tech
GWH
$21.8M
| $46.9K | ﹤0.01% |
3,820
-472
| -11% | -$5.32K |
|
4077
ThredUp
TDUP
$783M
| $46.7K | ﹤0.01% |
27,465
-24,219
| -47% | -$44.1K |
|
|
HUT
4078
CALL
Hut 8
HUT
$12.3B
| $46.5K | ﹤0.01% |
+3,100
| New | +$29.8K |
|
4079
Peoples Bancorp of North Carolina
PEBK
$233M
| $46.4K | ﹤0.01% |
1,590
+1,449
| +1,028% | +$42.4K |
|
4080
Invivyd
IVVD
$164M
| $46.4K | ﹤0.01% |
42,193
-160,638
| -79% | -$355K |
|
4081
Eastern Company
EML
$144M
| $46.4K | ﹤0.01% |
+1,820
| New | +$53K |
|
4082
Ginkgo Bioworks
DNA
$536M
| $46.1K | ﹤0.01% |
3,447
-6,227
| -64% | -$186K |
|
4083
Twin Disc
TWIN
$336M
| $46K | ﹤0.01% |
3,904
-10,755
| -73% | -$159K |
|
4084
Future Fuel
FF
$215M
| $45.5K | ﹤0.01% |
8,864
-9,760
| -52% | -$52.7K |
|
|
NAGE
4085
Niagen Bioscience
NAGE
$282M
| $45.3K | ﹤0.01% |
+16,600
| New | +$55.5K |
|
4086
Verrica Pharmaceuticals
VRCA
$92.8M
| $45.3K | ﹤0.01% |
621
-838
| -57% | -$64.4K |
|
|
HEAL
4087
Global X Funds Global X HealthTech ETF
HEAL
$29.1M
| $45.2K | ﹤0.01% |
1,721
| – | – |
|
4088
Cadiz
CDZI
$256M
| $44.8K | ﹤0.01% |
14,489
-14,063
| -49% | -$38.2K |
|
4089
EVI Industries
EVI
$184M
| $44.7K | ﹤0.01% |
2,363
-2,347
| -50% | -$48.8K |
|
|
MPX
4090
DELISTED
Marine Products Corp
MPX
| $44.6K | ﹤0.01% |
4,414
-2,836
| -39% | -$30.5K |
|
|
GOEV
4091
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $44.3K | ﹤0.01% |
1,040
-2,937
| -74% | -$144K |
|
4092
SeaStar Medical
ICU
$12.6M
| $44.3K | ﹤0.01% |
+583
| New | +$62.5K |
|
4093
Aclaris Therapeutics
ACRS
$708M
| $44.3K | ﹤0.01% |
40,245
-28,021
| -41% | -$32.9K |
|
|
LLAP
4094
DELISTED
Terran Orbital Corporation
LLAP
| $44K | ﹤0.01% |
53,676
-14,252
| -21% | -$15.3K |
|
|
EEX
4095
DELISTED
Emerald Holding
EEX
| $44K | ﹤0.01% |
7,733
-3,466
| -31% | -$20.8K |
|
4096
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.89B
| $43.8K | ﹤0.01% |
300
| – | – |
|
4097
STRATTEC Security
STRT
$372M
| $43.7K | ﹤0.01% |
1,748
| – | – |
|
4098
Tiziana Life Sciences
TLSA
$131M
| $43.7K | ﹤0.01% |
47,500
+30,000
| +171% | +$21.9K |
|
4099
HF Foods Group
HFFG
$80.7M
| $43.4K | ﹤0.01% |
14,468
-14,139
| -49% | -$45K |
|
4100
GrowGeneration
GRWG
$88.9M
| $43.3K | ﹤0.01% |
20,162
-23,812
| -54% | -$60.3K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.